News
Are you interested in learning about how to license from or collaborate with the NIH? Since the 1970s, the Intramural Research Program (IRP) has served as the in-house research and clinical arm of the NIH. Despite our success, many potential industry collaborators and licensees still see NIH solely
The CDC is searching for a licensee or collaborator for a new method to prevent HIV infection that has lower drug costs and lowers exposure to possible drug side effects. The current leading product to prevent HIV infection is daily pre-exposure prophylaxis (PrEP). However, many people find it
Inventors at the National Cancer Institute (NCI) have created a tool for developing new targeted therapies or enhancing patient stratification in transcriptomic multi-arm trials. This tool, named SELECT, uses a computational, precision-oncology framework that uses the tumor’s whole transcriptome to
Are you interested in licensing an automated digital pathology device? The National Cancer Institute (NCI) is seeking licensees to develop an automated digital pathology device that could be used for biopsy sample processing and applicable to diagnoses of various disease indications, including